Cosmo Pharmaceuticals NV
SIX:COPN

Watchlist Manager
Cosmo Pharmaceuticals NV Logo
Cosmo Pharmaceuticals NV
SIX:COPN
Watchlist
Price: 65 CHF Market Closed
Market Cap: 1B CHF
Have any thoughts about
Cosmo Pharmaceuticals NV?
Write Note

Operating Margin
Cosmo Pharmaceuticals NV

48.6%
Current
23%
Average
6.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
48.6%
=
Operating Profit
92.1m
/
Revenue
189.3m

Operating Margin Across Competitors

Country IE
Market Cap 1B CHF
Operating Margin
49%
Country JP
Market Cap 776 550.9T JPY
Operating Margin
-83%
Country US
Market Cap 761.8B USD
Operating Margin
35%
Country UK
Market Cap 440.4B GBP
Operating Margin
3%
Country DK
Market Cap 3.3T DKK
Operating Margin
44%
Country US
Market Cap 368.4B USD
Operating Margin
28%
Country US
Market Cap 250.9B USD
Operating Margin
34%
Country CH
Market Cap 208.8B CHF
Operating Margin
32%
Country CH
Market Cap 181.2B CHF
Operating Margin
29%
Country UK
Market Cap 158.6B GBP
Operating Margin
21%
Country IE
Market Cap 155B USD
Operating Margin
11%

Profitability Report

View the profitability report to see the full profitability analysis for Cosmo Pharmaceuticals NV.

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
48.6%
=
Operating Profit
92.1m
/
Revenue
189.3m
What is the Operating Margin of Cosmo Pharmaceuticals NV?

Based on Cosmo Pharmaceuticals NV's most recent financial statements, the company has Operating Margin of 48.6%.